4//SEC Filing
GARRETT MARVIN J 4
Accession 0001181431-12-036809
CIK 0000930553other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:51 PM ET
Size
38.5 KB
Accession
0001181431-12-036809
Insider Transaction Report
Form 4
GARRETT MARVIN J
Vice President, QC, Compliance
Transactions
- Disposition to Issuer
Option (right to buy)
2012-06-06−6,125→ 0 totalExercise: $9.41Exp: 2014-02-05→ Common Stock (6,125 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−26,482→ 0 totalExercise: $4.46Exp: 2018-02-08→ Common Stock (26,482 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−16,182→ 0 totalExercise: $6.77Exp: 2016-02-16→ Common Stock (16,182 underlying) - Disposition to Issuer
Common Stock
2012-06-06$9.10/sh−155,777$1,417,571→ 0 total - Disposition to Issuer
Option (right to buy)
2012-06-06−104,875→ 0 totalExercise: $3.75Exp: 2021-11-30→ Common Stock (104,875 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−25,724→ 0 totalExercise: $6.82Exp: 2021-02-07→ Common Stock (25,724 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−17,113→ 0 totalExercise: $6.82Exp: 2021-02-07→ Common Stock (17,113 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−11,296→ 0 totalExercise: $3.63Exp: 2020-02-02→ Common Stock (11,296 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−18,375→ 0 totalExercise: $3.63Exp: 2020-02-02→ Common Stock (18,375 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−7,875→ 0 totalExercise: $1.04Exp: 2019-02-03→ Common Stock (7,875 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−19,247→ 0 totalExercise: $1.04Exp: 2019-02-03→ Common Stock (19,247 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−9,240→ 0 totalExercise: $10.27Exp: 2015-02-17→ Common Stock (9,240 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−10,760→ 0 totalExercise: $10.27Exp: 2015-02-17→ Common Stock (10,760 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−23,081→ 0 totalExercise: $7.43Exp: 2017-02-02→ Common Stock (23,081 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−50,697→ 0 totalExercise: $3.49Exp: 2012-12-16→ Common Stock (50,697 underlying) - Disposition to Issuer
Option (right to buy)
2012-06-06−14,875→ 0 totalExercise: $9.41Exp: 2014-02-05→ Common Stock (14,875 underlying)
Footnotes (16)
- [F1]Disposed of pursuant to agreement and plan of Merger Agreement by and among the Company, Bausch & Lomb Incorporated and Inga Acquisition Corporation, as amended (the "Merger Agreement") in exchange for $9.10 per share, without interest, less any applicable withholding tax, on the effective date of the merger.
- [F10]The option which was fully vested on 12/02/09 was cancelled in the Merger Agreement in exchange for a cash payment equal to $1.67 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F11]The option which was fully vested on 12/16/08 was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.33 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F12]The option which was fully vested on 12/16/05 was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.61 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F13]The option which was fully vested on 12/17/07 was cancelled in the Merger Agreement.
- [F14]The option which was fully vested on 12/17/09 was cancelled in the Merger Agreement.
- [F15]The option which was fully vested on 12/05/06 was cancelled in the Merger Agreement.
- [F16]The option which was fully vested on 02/05/08 was cancelled in the Merger Agreement.
- [F2]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.35 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F3]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F4]The option of which 5,525 shares were unvested and 11,588 shares were vested was cancelled in the Merger Agreement in exchange for a cash payment equal to $2.28 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F5]The option which was fully vested on 12/02/11 was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F6]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $5.47 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F7]The option which was unvested was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F8]The option which was fully vested on 12/3/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $8.06 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
- [F9]The option which was fully vested on 12/08/10 was cancelled in the Merger Agreement in exchange for a cash payment equal to $4.64 per share (representing the difference between the exercise price of the option and the merger consideration of $9.10).
Documents
Issuer
ISTA PHARMACEUTICALS INC
CIK 0000930553
Entity typeother
Related Parties
1- filerCIK 0001216987
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:51 PM ET
- Size
- 38.5 KB